Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness

People who take certain medications for diabetes or obesity may have a higher risk of developing a rare form of blindness, according to a new study. The study found a potential association between semaglutide medications and non-arteritic anterior ischemic optic neuropathy (NAION), a type of eye stroke causing sudden vision loss. However, experts stress that the risk should not discourage patients from using these medications, as NAION remains relatively rare. Further research is needed to examine this association in a larger and more diverse population. Patients are advised to discuss the risks and benefits with their doctors.